OKYO Pharma Limited
OKYO
$1.61
$0.042.55%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.61M | -4.66M | -4.71M | -7.70M | -10.69M |
| Total Depreciation and Amortization | 2.20K | 2.40K | 2.60K | 2.80K | 3.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.76M | 2.51M | 1.27M | 2.69M | 4.10M |
| Change in Net Operating Assets | -2.25M | -309.30K | 1.63M | 2.63M | 3.64M |
| Cash from Operations | -3.10M | -2.45M | -1.81M | -2.38M | -2.94M |
| Capital Expenditure | -1.20K | -1.20K | -1.20K | -600.00 | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.20K | -1.20K | -1.20K | -600.00 | -- |
| Total Debt Issued | 948.20K | 949.10K | 950.00K | 475.90K | 1.80K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.47M | 3.59M | 1.71M | 2.23M | 2.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.42M | 4.54M | 2.66M | 2.71M | 2.76M |
| Foreign Exchange rate Adjustments | -88.80K | -99.20K | -109.60K | -280.60K | -451.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.23M | 1.98M | 734.20K | 52.00K | -630.20K |